PMGC Holdings (ELAB) Assets Average (2023 - 2026)
PMGC Holdings (ELAB) posted Assets Average of $19.5 million for Q1 2026, up 39.9% sequentially from $13.9 million in Q4 2025, and up 117.55% YoY from $8.9 million in Q1 2025.
PMGC Holdings (ELAB) Assets Average (2023 - 2026) Analysis & Trends
PMGC Holdings has reported Assets Average for 4 years, with the latest figure at $19.5 million in Q1 2026.
- Quarterly Assets Average rose 117.55% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 117.55% YoY) and the FY2025 annual result came in at $10.9 million, up 54.14% from the prior year.
- Assets Average advanced to $19.5 million in Q1 2026 per ELAB's latest filing, from $13.9 million in the prior quarter.
- Over five years, Assets Average peaked at $794.1 million in Q4 2023 and troughed at $4.7 million in Q2 2024.
- A 4-year average of $88.5 million and a median of $9.6 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2026: Assets Average tumbled 98.73% in 2024, then soared 117.55% in 2026.
- Over 4 years, Assets Average stood at $794.1 million in 2023, then sank by 98.73% to $10.1 million in 2024, then surged by 37.67% to $13.9 million in 2025, then surged by 39.9% to $19.5 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $19.5 million, $13.9 million, and $12.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | 19.82 Bn |
| 10 | PMGC Holdings | 30.23 Mn | 11.44 Mn | 385,691.00 | 31.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.45 Mn |
| Dec 31, 2025 | 13.90 Mn |
| Sep 30, 2025 | 12.16 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.94 Mn |
| Dec 31, 2024 | 10.10 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 4.65 Mn |
| Mar 31, 2024 | 4.71 Mn |
| Dec 31, 2023 | 794.09 Mn |